NCT03676959 A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Recurrent or Metastatic Cervical Cancer Status UNKNOWN Phase PHASE1
NCT03668639 Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin Status UNKNOWN Phase PHASE2/PHASE3
NCT03659110 Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice Status UNKNOWN Phase N/A
NCT03655977 Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer Status UNKNOWN Phase NA
NCT03652077 A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies Status COMPLETED Phase PHASE1
NCT03644459 Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 Status WITHDRAWN Phase PHASE1
NCT03635567 Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) Status COMPLETED Phase PHASE3
NCT03628118 A Research on Hidden Blood Loss in Open Radical Hysterectomy and Pelvic Lymphadenectomy Status UNKNOWN Phase N/A
NCT03614949 SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03613493 Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention Status TERMINATED Phase NA
NCT03611517 Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer Status UNKNOWN Phase NA
NCT03604653 Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers Status COMPLETED Phase N/A
NCT03602079 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Status COMPLETED Phase PHASE1/PHASE2
NCT03595722 Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers Status UNKNOWN Phase NA
NCT03578406 HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer Status COMPLETED Phase PHASE1
NCT03559803 A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer Status UNKNOWN Phase NA